Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
For individuals who have already tried semaglutide or tirzepatide with insufficient results, Retatrutide represents a logical escalation option
When food sits in the stomach longer and stomach acid production decreases, the body ability to extract vitamin B12 from dietary sources drops significantly
If you are at this concentration and this dose, you have two options
Screenshot 2025-08-18 at 7.31.56 PM844504 161 KB Eli lilly - Retatrutide (Once weekly, subcutaneous) Retatrutide is a novel, once-weekly injectable triple agonist that targets the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon receptors
Where to inject: The back or outer side of the upper arm is usually best
Your endocrinologist will help determine the appropriate duration of therapy and develop a long-term maintenance strategy
US$ 28.03
US$ 26.00
US$ 29.66
